Appointments: EFPIA, Celgene, AcelRx, PureTech Health, Symbiomix, CRISPR Therapeutics and Achaogen

09 Mar 2017

• By Lubna Ahmed

This latest roundup includes EFPIA's appointment of Nathalie Moll to director general, CEO appointments by YposKesi and Symbiomix Therapeutics, as well as various executive appointments by PureTech Health, Arterial Capital Management and Mitra Biotech.

Nathalie Moll, currently secretary general of the European Association for Bioindustries,has been appointed EFPIA's director general – effective April, 2017. Eric Cornut will continue to lead EFPIA as interim director general until Moll joins the organization.

Celgene Corp.‘s president and chief operating officer (COO), Jacqualyn Fouse, will be retiring from the company – effective June...